On the basis of our findings, we propose not only the upregulation of CD200 on tumor cells, but also CD200R1 overexpression on stromal cells in terms of the interaction between CD200 and its receptor CD200R1, which are the hallmark of metastatic rectal cancer and potentially responsible for supporting the survival of CD200 expressing tumor cells. The gene discussed is CD200; the disease is neoplasm.